Core and Group Health

The class-action lawsuit against both Cigna and OptumRx Inc. alleges the two companies conspired over several years to make consumers pay higher prices for prescription drugs.

A first-of-its-kind study confirms what we all suspected: doctors receiving payments from drug companies are more likely to prescribe those drugs than cheaper alternatives.

The bill would prohibit insurers and pharmacy benefit managers from restricting a pharmacy's ability to tell customers the difference in price between a prescription purchased with insurance or out of pocket.

New cards will be sent to people covered by Medicare on a rolling basis over a 12-month period ending in April 2019.

A LIMRA/IRI study results indicate there is much to be done to educate consumers, advisors and employers of the full benefits of HSAs.

The federal budget agreement Congress approved last month removes annual caps on how much Medicare pays for physical, occupational or speech therapy,